Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Viral hepatitis: clinical aspects.

A G Redeker

    The American Journal of the Medical Sciences
    |July 1, 1975
    PubMed
    Summary
    This summary is machine-generated.

    Most acute viral hepatitis cases resolve fully. However, some patients develop persistent or chronic active hepatitis, with a small percentage progressing to cirrhosis, particularly after type B infections.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Hyperfibrinolytic activity in hospitalized cirrhotic patients in a referral liver unit.

    The American journal of gastroenterology·2001
    Same author

    Viral, host and interferon-related factors modulating the effect of interferon therapy for hepatitis C virus infection.

    Journal of viral hepatitis·2001
    Same author

    Acute hepatitis induced by bupropion.

    Digestive diseases and sciences·2000
    Same author

    Intrahepatic HCV levels in chronic HCV infection.

    Gut·1999
    Same author

    Cyclosporine therapy in patients with steroid resistant autoimmune hepatitis.

    The American journal of gastroenterology·1999
    Same author

    A pilot randomized, controlled trial of the effect of iron depletion on long-term response to alpha-interferon in patients with chronic hepatitis C.

    Journal of hepatology·1998
    Same journal

    Providers' Perspectives on Hospital-Based Tobacco Treatment Efforts.

    The American journal of the medical sciences·2026
    Same journal

    In Memoriam: Maurice A. Mufson, MD, MACP.

    The American journal of the medical sciences·2026
    Same journal

    Outcomes of acute myeloid leukemia patients admitted to the intensive care unit within 100 days of allogeneic hematopoietic stem cell transplantation.

    The American journal of the medical sciences·2026
    Same journal

    Association Between Reverse Triiodothyronine and Cardiac Complications in Patients with Uncontrolled Graves' Disease.

    The American journal of the medical sciences·2026
    Same journal

    Chlorthalidone vs. hydrochlorothiazide in hypertension management: Lessons for guiding clinical practice.

    The American journal of the medical sciences·2026
    Same journal

    The impact of COVID-19 on alcohol-associated hepatitis and alcohol-associated cirrhosis.

    The American journal of the medical sciences·2026
    See all related articles

    Area of Science:

    • Hepatology
    • Virology
    • Immunology

    Background:

    • Acute viral hepatitis typically resolves without long-term consequences.
    • Fulminant hepatitis, though rare, has a significant mortality rate, but survivors generally do not develop chronic liver disease.
    • Persistent and chronic active hepatitis are potential sequelae of acute viral hepatitis.

    Purpose of the Study:

    • To investigate the long-term outcomes of acute viral hepatitis.
    • To determine the incidence of persistent and chronic active hepatitis following acute infections.
    • To analyze the progression of chronic active hepatitis and factors associated with it.

    Main Methods:

    • Observational study analyzing patient outcomes following acute viral hepatitis.
    • Follow-up of patients with acute icteric hepatitis (type B and non-B).

    Related Experiment Videos

  • Monitoring of Hepatitis B surface antigen (HBs Ag) in carriers and patients with chronic active hepatitis.

    • Main Results:

    • The majority of acute viral hepatitis cases resolve completely.
    • Persistent viral hepatitis occurred in 10-12% of patients after acute icteric hepatitis.
    • Chronic active viral hepatitis, a sequela of acute icteric type B hepatitis in 3% of patients, can progress to cirrhosis.
    • Hepatitis B surface antigen (HBs Ag) clearance was observed in long-term carriers.
    • Low titers of HBs Ag are common in patients with chronic active type B hepatitis.

    Conclusions:

    • While most acute viral hepatitis infections are self-limiting, a subset of patients may develop persistent or chronic active forms.
    • Chronic active hepatitis, particularly following type B infection, carries a risk of progression to cirrhosis.
    • Hepatitis B surface antigen (HBs Ag) clearance is possible in some chronic carriers over time.